Samsung Bioepis Grows After US Launches

Ustekinumab And Eculizumab Introduced; Denosumab On The Way

 
• By Dave Wallace
  
Recent launches have driven Q1 growth for Samsung Bioepis (Shutterstock)

More from Earnings

More from Products